{"name":"BZ Bank","permalink":"bz-bank","crunchbase_url":"http://www.crunchbase.com/financial-organization/bz-bank","homepage_url":"http://www.bzbank.ch","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"41-44-786-61-11","description":"Swiss Banking Firm","email_address":"info@bzbank.ch","number_of_employees":null,"founded_year":1985,"founded_month":5,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Wed Jun 17 21:31:51 UTC 2009","updated_at":"Mon Aug 31 21:56:06 UTC 2009","overview":"<p>BZ Bank Aktiengesellschaft was founded by Martin Ebner in May 1985. The main services include securities trading, equities brokerage, wealth management and advisory services for selected clients, issuing of covered warrants, asset management, as well as Corporate Finance activities and M&amp;A advisory services. As a result of the specialization of the banking activities, the main source of revenue are trading commissions and advisory fees.</p>","image":{"available_sizes":[[[108,87],"assets/images/resized/0005/8240/58240v1-max-150x150.png"],[[108,87],"assets/images/resized/0005/8240/58240v1-max-250x250.png"],[[108,87],"assets/images/resized/0005/8240/58240v1-max-450x450.png"]],"attribution":null},"offices":[{"description":"","address1":"Egglirain 15","address2":"","zip_code":"CH-8832","city":"Wilen","state_code":null,"country_code":"CHE","latitude":47.1996843,"longitude":8.7327675}],"relationships":[],"investments":[{"funding_round":{"round_code":"c","source_url":"http://www.novimmune.com/about-us/history.html","source_description":"Company History","raised_amount":53000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":6,"funded_day":null,"company":{"name":"NovImmune","permalink":"novimmune","image":{"available_sizes":[[[150,44],"assets/images/resized/0004/9228/49228v1-max-150x150.png"],[[250,74],"assets/images/resized/0004/9228/49228v1-max-250x250.png"],[[262,78],"assets/images/resized/0004/9228/49228v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://onbiovc.com/novimmune-sa-series-c-548m/","source_description":"NovImmune, SA: Series C $54.8M","raised_amount":54800000,"raised_currency_code":"USD","funded_year":2009,"funded_month":5,"funded_day":12,"company":{"name":"NovImmune","permalink":"novimmune","image":{"available_sizes":[[[150,44],"assets/images/resized/0004/9228/49228v1-max-150x150.png"],[[250,74],"assets/images/resized/0004/9228/49228v1-max-250x250.png"],[[262,78],"assets/images/resized/0004/9228/49228v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.novimmune.com/geneva-switzerland-december-17th-2010-2.html","source_description":"NovImmune raises additional CHF 20 million ","raised_amount":20600000,"raised_currency_code":"USD","funded_year":2010,"funded_month":12,"funded_day":17,"company":{"name":"NovImmune","permalink":"novimmune","image":{"available_sizes":[[[150,44],"assets/images/resized/0004/9228/49228v1-max-150x150.png"],[[250,74],"assets/images/resized/0004/9228/49228v1-max-250x250.png"],[[262,78],"assets/images/resized/0004/9228/49228v1-max-450x450.png"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}